Researchers in the US have developed a prototype of a wearable device that can monitor oestrogen in sweat and could play a role in women’s health and fertility.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh